Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report
Cureus · 27.09.2026
DOI: 10.7759/cureus.117018 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 27.09.2026. Verfasst von Joselyn De Jesus-Gonzalez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Drug-induced mucosal injury may result from direct contact toxicity or immune-mediated adverse drug reactions. Although oxcarbazepine is a recognized etiology of severe hypersensitivity reactions, isolated oroesophageal mucosal injury without cutaneous or systemic involvement has not been previously described. We report a 68-year-old woman who developed severe diffuse esophagitis with concomitant oral mucosal ulceration approximately two weeks after oxcarbazepine initiation, with symptom onset within 24 hours of dose escalation from 150 to 300 mg twice daily. Histologic evaluation demonstrated predominantly lymphocytic esophageal inflammation with no evidence of infectious, eosinophilic, or immunobullous disease. The patient had no rash, peripheral eosinophilia, or systemic organ involvement. A Naranjo score of 7 supported a probable adverse drug reaction. Treatment consisted of discontinuation of oxcarbazepine alone, without the need for immunosuppressive or additional pharmacologic therapy. At five-month follow-up, the patient achieved endoscopic and histologic resolution. This case expands upon the recognized spectrum of oxcarbazepine-associated adverse drug reactions and emphasizes the importance of medication review in patients presenting with diffuse esophagitis and oral mucositis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA.
- Department of Pathology and Laboratory Medicine, Tampa General Hospital, Tampa, USA.
- Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, USA.
- Division of Digestive Disease and Nutrition, Morsani College of Medicine, University of South Florida, Tampa, USA.
- Division of Digestive Diseases and Nutrition, Joy McCann Culverhouse Center for Swallowing Disorders, Morsani College of Medicine, University of South Florida, Tampa, USA.
Zitieren
APA
De Jesus-Gonzalez, J., Federico, Q. P., Malafronte, P., Champeaux, A., Narayanan, S., & Jacobs, J. (2026). Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report. Cureus. https://doi.org/10.7759/cureus.117018
Vancouver
De Jesus-Gonzalez J, Federico QP, Malafronte P, Champeaux A, Narayanan S, Jacobs J. Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report. Cureus. 2026. doi:10.7759/cureus.117018
BibTeX
@article{DeJesusGonzalez2026,
author = {De Jesus-Gonzalez, Joselyn and Federico, Quinten P and Malafronte, Patrick and Champeaux, Anne and Narayanan, Shreya and Jacobs, John},
title = {Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.117018}
}
EUVIMED